• Luminex Receives EUA for COVID-19 Antibody Test americanpharmaceuticalreview
    July 27, 2020
    Luminex announced the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's xMAP® SARS-CoV-2 Multi-Antigen IgG Assay.
PharmaSources Customer Service